J1920 HCPCS code: Injection, labetalol hydrochloride, 5 mg
J1920 is the HCPCS Level II code for injection, labetalol hydrochloride, 5 mg. In 2024 Medicare paid an average of $0.16 per service for J1920 across 1,770 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. Medicare volume rose 266% from 2023 to 2024 (483 to 1,770 services). In 2024, about 123 clinicians billed Medicare for J1920 for 411 beneficiaries; California, Colorado, Florida accounted for 57% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2023-07-01 |
| Last action effective | 2024-01-01 |
Who bills J1920 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 123 |
| Medicare beneficiaries | 411 |
| States with claims | 11 |
| Share of services in top 3 states (California, Colorado, Florida) | 57% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J1920, 2023–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2023 | 483 | 69 | $0.20 | $0.16 |
| 2024 | 1,770 | 411 | $0.20 | $0.16 |
States with the most J1920 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| California | 322 | $0.15 |
| Colorado | 238 | $0.14 |
| Florida | 176 | $0.16 |
| North Carolina | 130 | $0.18 |
| Texas | 121 | $0.15 |
What changed for J1920
- 2023-07-01: J1920 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J1920?
J1920 is the HCPCS Level II code for injection, labetalol hydrochloride, 5 mg. Short descriptor: "Inj, labetalol hcl, 5mg".
How much does Medicare pay for J1920?
In 2024, the average Medicare payment was $0.16 per service (average allowed $0.20).
Does Medicare cover J1920?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
Related J19 codes
- J1921 — Injection, labetalol hydrochloride (hikma), not therapeutically equivalent to j1920, 5 mg
- J1930 — Injection, lanreotide, 1 mg
- J1931 — Injection, laronidase, 0.1 mg
- J1932 — Injection, lanreotide, (cipla), 1 mg
- J1938 — Injection, furosemide, 1 mg
- J1939 — Injection, bumetanide, 0.5 mg
- J1940 — Injection, furosemide, up to 20 mg
- J1941 — Injection, furosemide (furoscix), 20 mg
- J1942 — Injection, aripiprazole lauroxil, 1 mg
- J1943 — Injection, aripiprazole lauroxil, (aristada initio), 1 mg
- J1944 — Injection, aripiprazole lauroxil, (aristada), 1 mg
- J1945 — Injection, lepirudin, 50 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J1920
- Watch J1920 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J1920
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.